Literature DB >> 29450712

Artifacts during the arterial phase of gadoxetate disodium-enhanced MRI: Multiple arterial phases using view-sharing from two different vendors versus single arterial phase imaging.

Ji Hye Min1,2, Young Kon Kim3, Tae Wook Kang1, Woo Kyoung Jeong1, Won Jae Lee1, Soohyun Ahn4, Na Young Hwang4.   

Abstract

OBJECTIVES: To assess the usefulness of multiple arterial phase (AP) of gadoxetic acid-enhanced MRI using view-sharing of two different vendors to reduce transient severe motion (TSM) artifact in the AP.
METHODS: This retrospective study included 298 patients (mean age 63 years) who underwent gadoxetic acid MRI with multiple AP from two different vendors; either triple (subcohort A, n=174) or quadruple (subcohort B, n=124) AP. 202 patients (143 vs. 59) underwent follow-up MRI with single AP. To compare multiple AP with single AP and between subcohorts, mean artifact score rated by two observers and frequency of significant artifacts were evaluated. Frequency of acquisition of late AP was also assessed.
RESULTS: There was no difference in mean artifact score (p=0.086) or frequency of significant artifacts (p=0.219) between multiple AP and single AP. For the mean best score with multiple AP, subcohort B was better than subcohort A (p<0.001). Late AP was achieved more often with multiple AP (74.8 %, 98.3 %) than with single AP (64.3 %, 64.4 %).
CONCLUSION: Multiple AP using different view-sharing failed to show differences in TSM artifacts in AP compared to single AP. Frequency of acquisition of late AP was higher with multiple AP. Mean best artifact score of multiple AP is different depending on view-sharing technique. KEY POINTS: • TSM artifacts were not significantly different between multiple AP and single AP. • The frequency of acquiring late AP was higher with multiple AP. • For multiple APs, TSM artifacts are different according to view-sharing technique.

Entities:  

Keywords:  Artifact; Gadoxetic acid; Magnetic resonance imaging; Multiple arterial phase; View-sharing

Mesh:

Substances:

Year:  2018        PMID: 29450712     DOI: 10.1007/s00330-018-5307-4

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  28 in total

1.  Usefulness of controlled aliasing in parallel imaging results in higher acceleration in gadoxetic acid-enhanced liver magnetic resonance imaging to clarify the hepatic arterial phase.

Authors:  Yang Shin Park; Chang Hee Lee; In Seong Kim; Berthold Kiefer; Seung Tae Woo; Kyeong Ah Kim; Cheol Min Park
Journal:  Invest Radiol       Date:  2014-03       Impact factor: 6.016

2.  Contrast-enhanced timing robust acquisition order with a preparation of the longitudinal signal component (CENTRA plus) for 3D contrast-enhanced abdominal imaging.

Authors:  Gabriele M Beck; Jan De Becker; Alun C Jones; Marcus von Falkenhausen; Winfried A Willinek; Jürgen Gieseke
Journal:  J Magn Reson Imaging       Date:  2008-06       Impact factor: 4.813

3.  Improvement of gadoxetate arterial phase capture with a high spatio-temporal resolution multiphase three-dimensional SPGR-Dixon sequence.

Authors:  Thomas A Hope; Manojkumar Saranathan; Iva Petkovska; Brian A Hargreaves; Robert J Herfkens; Shreyas S Vasanawala
Journal:  J Magn Reson Imaging       Date:  2013-01-31       Impact factor: 4.813

4.  Hypervascular hepatocellular carcinoma: detection with double arterial phase multi-detector row helical CT.

Authors:  T Murakami; T Kim; M Takamura; M Hori; S Takahashi; M P Federle; K Tsuda; K Osuga; S Kawata; H Nakamura; M Kudo
Journal:  Radiology       Date:  2001-03       Impact factor: 11.105

5.  Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium: examination recovery with a multiple arterial phase acquisition.

Authors:  Jason A Pietryga; Lauren M B Burke; Daniele Marin; Tracy A Jaffe; Mustafa R Bashir
Journal:  Radiology       Date:  2014-01-21       Impact factor: 11.105

6.  Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.

Authors:  Utaroh Motosugi; Tomoaki Ichikawa; Hironobu Sou; Katsuhiro Sano; Licht Tominaga; Ali Muhi; Tsutomu Araki
Journal:  Radiology       Date:  2010-07       Impact factor: 11.105

7.  Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma.

Authors:  Sung Soo Ahn; Myeong-Jin Kim; Joon Seok Lim; Hye-Suk Hong; Yong Eun Chung; Jin-Young Choi
Journal:  Radiology       Date:  2010-05       Impact factor: 11.105

8.  Transient severe motion in the arterial phase during gadoxetate disodium-enhanced MR imaging: evaluation of patients with multiple MR examinations.

Authors:  Won Hyeong Im; Ji Soo Song; Eun Hae Park; Hyo Sung Kwak
Journal:  Abdom Radiol (NY)       Date:  2017-10

9.  CAIPIRINHA-Dixon-TWIST (CDT)-volume-interpolated breath-hold examination (VIBE) for dynamic liver imaging: comparison of gadoterate meglumine, gadobutrol and gadoxetic acid.

Authors:  Johannes Budjan; Melissa Ong; Philipp Riffel; John N Morelli; Henrik J Michaely; Stefan O Schoenberg; Stefan Haneder
Journal:  Eur J Radiol       Date:  2014-08-17       Impact factor: 3.528

10.  Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings.

Authors:  Alexander Huppertz; Thomas Balzer; Anthony Blakeborough; Josy Breuer; Andrea Giovagnoni; Gertraud Heinz-Peer; Michael Laniado; Riccardo M Manfredi; Didier G Mathieu; Dieter Mueller; Peter Reimer; Philip J Robinson; Michael Strotzer; Matthias Taupitz; Thomas J Vogl
Journal:  Radiology       Date:  2004-01       Impact factor: 11.105

View more
  5 in total

1.  Second shot arterial phase to overcome degraded hepatic arterial phase in liver MR imaging.

Authors:  Yang Shin Park; Jongmee Lee; Jeong Woo Kim; Cheol Min Park; Chang Hee Lee
Journal:  Eur Radiol       Date:  2018-12-14       Impact factor: 5.315

2.  Gadoxetate disodium-related event during image acquisition: a prospective multi-institutional study for better MR practice.

Authors:  Marie-Luise Kromrey; Masatoshi Hori; Satoshi Goshima; Kazuto Kozaka; Tomoko Hyodo; Yuko Nakamura; Akihiro Nishie; Tsutomu Tamada; Tatsuya Shimizu; Akihiko Kanki; Utaroh Motosugi
Journal:  Eur Radiol       Date:  2019-07-23       Impact factor: 5.315

3.  Influence of dilution on arterial-phase artifacts and signal intensity on gadoxetic acid-enhanced liver MRI.

Authors:  Sarah Poetter-Lang; Gregor O Dovjak; Alina Messner; Raphael Ambros; Stephan H Polanec; Pascal A T Baltzer; Antonia Kristic; Alexander Herold; Jacqueline C Hodge; Michael Weber; Nina Bastati; Ahmed Ba-Ssalamah
Journal:  Eur Radiol       Date:  2022-07-27       Impact factor: 7.034

4.  Reduction of respiratory motion artifacts in gadoxetate-enhanced MR with a deep learning-based filter using convolutional neural network.

Authors:  M-L Kromrey; D Tamada; H Johno; S Funayama; N Nagata; S Ichikawa; J-P Kühn; H Onishi; U Motosugi
Journal:  Eur Radiol       Date:  2020-06-17       Impact factor: 5.315

5.  Evaluation of late arterial acquisition and image quality after gadoxetate disodium injection using the CDT-VIBE sequence.

Authors:  Fen Liu; Feng Ma; Guanlan Zhou; Chongtu Yang; Bin Xiong
Journal:  Sci Rep       Date:  2022-07-06       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.